NIRVANA-1: Maintenance therapy with niraparib versus niraparib –bevacizumab in patients with advanced ovarian cancer - supplementary material
收藏NIAID Data Ecosystem2026-05-01 收录
数据链接：
官方服务：
资源简介：
Criteria for discontinuing allocated interventions for participant and dose modifications
创建时间：
2023-08-31
